Value of routine test for identifying colorectal cancer from patients with nonalcoholic fatty liver disease

被引:4
|
作者
Yang, Rong [1 ]
Chen, Yu [2 ]
Chen, Xianlai [3 ,4 ]
机构
[1] Cent South Univ, Xiangya Hosp, Changsha 410078, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China
[3] Cent South Univ, Inst Informat Secur & Big Data, 932 South Lushan Rd, Changsha 410083, Hunan, Peoples R China
[4] Cent South Univ, Natl Engn Lab Med Big Data Applicat Technol, Changsha 410083, Hunan, Peoples R China
基金
国家重点研发计划;
关键词
Nonalcoholic fatty liver disease; Colorectal neoplasms; Diagnostic tests; routine; Early detection of Cancer; RISK; ASSOCIATION; SERUM;
D O I
10.1186/s12876-020-01327-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Nonalcoholic fatty liver disease (NAFLD) is a risk factor for colorectal neoplasms. Our goal is to explore the relationship between NAFLD and colorectal cancer (CRC) and to analyze potential indicators for screening CRC in NAFLD based on clinical big data. Methods Demographic information and routine clinical indicators were extracted from Xiangya Medical Big Data Platform. 35,610 NAFLD cases without CRC (as group NAFLD-CRC), 306 NAFLD cases with CRC (as group NAFLD-NonCRC) and 10,477 CRC cases without NAFLD were selected and evaluated. The CRC incidence was compared between NAFLD population and general population by Chi-square test. Independent sample t-test was used to find differences of age, gender and routine clinical indicators in pairwise comparisons of NAFLD-CRC, NAFLD-NonCRC and nonNAFLD-CRC. Results NAFLD population had a higher CRC incidence than general population (7.779 parts per thousand vs 3.763 parts per thousand,P < 0.001). Average age of NAFLD-CRC (58.79 +/- 12.353) or nonNAFLD-CRC (59.26 +/- 13.156) was significantly higher than NAFLD-nonCRC (54.15 +/- 14.167,p < 0.001). But age had no significant difference between NAFLD-CRC and nonNAFLD-CRC (P > 0.05). There was no different gender distribution for three groups (P > 0.05). NAFLD-CRC had lower anaemia-related routine clinical indicators such as decrease of red blood cell count, mean hemoglobin content and hemoglobin than NAFLD-nonCRC (P < 0.05 for all). Anemia of NAFLD-CRC was typical but it might be slighter than nonNAFLD-CRC. More interestingly, NAFLD-CRC had distinct characteristics of leukocyte system such as lower white blood cell count (WBC) and neutrophil count (NEU_C) and higher basophil percentage (BAS_Per) than nonNAFLD-CRC and NAFLD-nonCRC (P < 0.05 for all). Compared with NAFLD-nonCRC, the change of WBC, BAS_Per and NEU_C in NAFLD-CRC was different from that in nonNAFLD-CRC. In addition, NAFLD-CRC had a higher level of low density lipoprotein (LDL) and high density lipoprotein (HDL), lower level of triglyceride (TG) and Albumin-to-globulin ratio (A/G) than NFLD-nonCRC (P < 0.05 for all). Conclusions NAFLD is associated with a high incidence of CRC. Age is an important factor for CRC and the CRC incidence increases with age. Anemia-related blood routine clinical indicators, leukocyte system and blood lipid indicators may be more important variables for identifying CRC in NAFLD. So blood routine test and liver function/blood lipid test are valuable for screening CRC in NAFLD.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease
    Kara, Muammer
    Dogru, Teoman
    Genc, Halil
    Sertoglu, Erdim
    Celebi, Gurkan
    Gurel, Hasan
    Kayadibi, Huseyin
    Cicek, Ali F.
    Ercin, Cemal N.
    Sonmez, Alper
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (10) : 1144 - 1148
  • [32] Diagnosis and assessment of disease severity in patients with nonalcoholic fatty liver disease
    Li, Jie
    Delamarre, Adele
    Wong, Vincent Wai-Sun
    de Ledinghen, Victor
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (02) : 219 - 225
  • [33] Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease
    Shibata, Naoki
    Ito, Takanori
    Toyoda, Hidenori
    Tanaka, Akihito
    Morita, Yasuhiro
    Kanzaki, Yasunori
    Watanabe, Naoki
    Yoshioka, Naoki
    Yasuda, Satoshi
    Morishima, Itsuro
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (09) : 2115 - 2123
  • [34] Increased Prevalence of Colorectal Adenomas in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study
    Blackett, John William
    Verna, Elizabeth C.
    Lebwohl, Benjamin
    DIGESTIVE DISEASES, 2020, 38 (03) : 222 - 230
  • [35] Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    Potze, Wilma
    Siddiqui, M. Shadab
    Sanyal, Arun J.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (05) : 488 - 493
  • [36] The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm
    Pan, Shuang
    Hong, Wandong
    Wu, Wenzhi
    Chen, Qinfen
    Zhao, Qian
    Wu, Jiansheng
    Jin, Yin
    MEDICINE, 2017, 96 (02)
  • [37] Hyperferritinemia in patients with nonalcoholic fatty liver disease
    Barros, Raffaelle K.
    Cotrim, Helma Pinchemel
    Daltro, Carla H.
    Oliveira, Yanaihara A.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (03): : 284 - 289
  • [38] Irisin in patients with nonalcoholic fatty liver disease
    Polyzos, Stergios A.
    Kountouras, Jannis
    Anastasilakis, Athanasios D.
    Geladari, Eleni V.
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (02): : 207 - 217
  • [39] Serum Biomarkers in Sudanese Patients with Nonalcoholic Fatty Liver Disease
    Altoum, Abdelgadir Alamin
    Zayyad, Sofiyat
    Yousef, Ibrahim
    Shemote, Zulekha
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2024, 14 (03) : 520 - 523
  • [40] Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia
    Blais, Pierre
    Lin, Michael
    Kramer, Jennifer R.
    El-Serag, Hashem B.
    Kanwal, Fasiha
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (06) : 1714 - 1720